Document:

Exhibit 10.6

 Exhibit 10.6 

WARRANT AGREEMENT 

Agreement made as of             , 2010 between Madison
Square Capital, Inc., a Maryland corporation, with offices at 331 West
57th Street, #363, New York, New York 10019
(“Company”), and Registrar and Transfer Company, a New Jersey corporation, with offices at 10 Commerce Drive, Cranford, New Jersey 07016 (“Warrant Agent”). 

WHEREAS, the Company is engaged in an initial public offering (“Public Offering”) of units of the Company (the
“Units”) and, in connection therewith, has determined to issue and deliver up to 10,000,000 warrants (the “Warrants”) to the investors in the Public Offering pursuant to an underwriting agreement, dated
            , 2010, by and between the Company and the several underwriters listed on Schedule I thereto (the “Underwriters”), each Warrant evidencing the right of the
holder thereof to purchase one share of common stock, $.01 par value per share, of the Company (the “Common Stock”) for $        , subject to adjustment as described herein; and 

WHEREAS, the Company has filed with the Securities and Exchange Commission a Registration Statement on Form S-11, No. 333-150467
(“Registration Statement”), for the registration, under the Securities Act of 1933, as amended (“Act”) of the offering of, among other securities, the Warrants and the Common Stock issuable upon exercise of the Warrants; and

 WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act,
in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; and 
 WHEREAS, the
Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of
the Warrants; and 
 WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when
executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement. 

NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows: 

1. Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant
Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement. 

 2. Warrants. 

2.1. Form of Warrant. Each Warrant shall be issued in registered form, shall be in substantially the form of Exhibit A
hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, (i) the Chairman of the Board or President and (ii) the Treasurer, Secretary or Assistant Secretary of the Company and
shall bear a facsimile of the Company’s seal. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued,
it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance. 
 2.2. Effect of
Countersignature. Unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof. 

2.3. Registration. 

2.3.1. Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”), for the registration of original
issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in
accordance with instructions delivered to the Warrant Agent by the Company. 
 2.3.2. Registered Holder. Prior to due
presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant shall be registered upon the Warrant Register (“registered holder”), as the absolute owner
of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on the Warrant Certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and
for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. 
 2.4.
Detachability of Warrants. The securities comprising the Units will not be separately transferable until 35 days after the date hereof unless Lazard Capital Markets LLC (“Lazard”) and Stifel, Nicolaus & Company,
Incorporated (“Stifel”) inform the Company of the Underwriters’ decision to allow earlier separate trading. 
 3. Terms and
Exercise of Warrants  
 3.1. Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the
registered holder thereof, subject to the provisions of such Warrant and of this Warrant Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $        
per whole share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Warrant Agreement refers to the price per share at which Common Stock
may be purchased at 
  

 2 

 
the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date for a period of not less than 10 business days; provided,
however, that any such reduction shall be identical in percentage terms among all of the Warrants. 
 3.2. Duration of
Warrants. A Warrant may be exercised only during the period (“Exercise Period”) commencing on the date the securities comprising the Units are permitted to trade separately and terminating at 5:00 p.m., New York time on the earlier to
occur of (i)             , 20     or (ii) the date fixed for redemption of the Warrants as provided in Section 6 of this Agreement
(“Expiration Date”). Except with respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder), each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and
all rights in respect thereof under this Agreement shall cease at the close of business on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, however, that the
Company will provide notice to registered holders of the Warrants of such extension of not less than 20 days. 
 3.3.
Exercise of Warrants. 
 3.3.1. Payment. Subject to the provisions of the Warrant and this Warrant Agreement, a
Warrant, when countersigned by the Warrant Agent, may be exercised by the registered holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor as Warrant Agent, with the exercise form on the reverse
side of the Warrant duly executed, and by paying in full the Warrant Price for each full share of Common Stock as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, as follows:

  

	 	(a)	good certified check or good bank draft payable to the order of the Company (or as otherwise agreed to by the Company); or 

 

	 	(b)	in the event of redemption pursuant to Section 6 hereof in which the Company has elected to force all holders of Warrants to exercise such Warrants on a
“cashless basis,” by surrendering the Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the
difference between the Warrant Price and the “Fair Market Value” by (y) the Fair Market Value. Solely for purposes of this Section 3.3.1(b), the “Fair Market Value” shall mean the average reported last sale price of the
Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to holders of Warrant pursuant to Section 6 hereof. 

3.3.2. Issuance of Certificates. As soon as practicable after the exercise of any Warrant and the clearance of the funds in
payment of the Warrant Price, the Company shall issue to the registered holder of such Warrant a certificate or certificates for the number of full shares 

 

 3 

 
of Common Stock to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new
countersigned Warrant for the number of shares as to which such Warrant shall not have been exercised. Subject to Section 7.4 and notwithstanding the foregoing, the Company shall not be obligated to deliver any securities pursuant to the
exercise of a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Act with respect to the Common Stock issuable upon exercise of the Warrants is effective and a current prospectus relating
to such Common Stock is available, or in the opinion of counsel to the Company, the exercise of the Warrants is exempt from the registration requirements of the Act and such securities are qualified for sale or exempt from qualification under
applicable securities laws of the states or other jurisdictions in which the registered holders reside. In the event that a registration statement with respect to the Common Stock underlying a Warrant is not effective under the Act and a current
prospectus relating to such Common Stock is not available, the holder of such Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless. In no event (whether in the case of a registration
statement not being effective or otherwise) will (i) the Company be required to net cash settle the exercise of the Warrants or (ii) the holder of a Warrant be permitted to satisfy the payment of the Exercise Price by tendering to the
Company his or her shares of Common Stock. Warrants may not be exercised by, or securities issued to, any registered holder in any state in which such exercise would be unlawful. In the event that a registration statement is not effective for the
exercised Warrants and a current prospectus relating to such Common Stock is not available, the purchaser of a Unit containing such Warrant will have paid the full purchase price for the Unit solely for the shares of Common Stock included in such
Unit. 
 3.3.3. Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity
with this Agreement shall be validly issued, fully paid and nonassessable. 
 3.3.4. Date of Issuance. Each person in
whose name any such certificate for shares of Common Stock is issued shall for all purposes be deemed to have become the holder of record of such shares on the date on which the Warrant was surrendered and payment of the Warrant Price was made,
irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of such shares
at the close of business on the next succeeding date on which the stock transfer books are open. 
 3.3.5. Restrictions on
Exercise of Warrants. Notwithstanding anything to the contrary contained herein, no Warrant may be exercised if it would cause the holder to Beneficially Own or Constructively Own, within the meaning of the Company’s charter,
outstanding Common Stock in excess of the Stock Ownership Limit or Excepted Holder Limit. Defined terms used in this Section 3.3.5 that are not otherwise defined in this Agreement shall have the meaning provided for in the Company’s
charter. 
  

 4 

 4. Adjustments. 

The number of shares of Common Stock issuable upon the exercise of each Warrant is subject to adjustment from time to time upon the
occurrence of the events enumerated in this Section 4. For purposes of this Section 4, “Common Stock” means shares now or hereafter authorized of any class of common stock of the Company and any other stock of the Company,
however designated, that has the right (subject to any prior rights of any class or series of preferred stock) to participate in any distribution of the assets or earnings of the Company without limit as to per share amount. 

4.1. Adjustment for Change in Capital Stock. If the Company: 

(1) pays a dividend or makes a distribution on its Common Stock, in either case, in shares of its Common Stock; 

(2) subdivides its outstanding shares of Common Stock into a greater number of shares; 

(3) combines its outstanding shares of Common Stock into a smaller number of shares; 

(4) makes a distribution on its Common Stock in shares of its capital stock other than Common Stock; or 

(5) issues by reclassification of its Common Stock any shares of its capital stock; 

then the number of shares of Common Stock issuable upon exercise of each Warrant immediately prior to such action shall be proportionately adjusted so
that the holder of any Warrant thereafter exercised shall receive the aggregate number and kind of shares of capital stock of the Company which he would have owned immediately following such action if such Warrant had been exercised immediately
prior to such action. 
 The adjustment shall become effective immediately after the record date in the case of a dividend or
distribution and immediately after the effective date in the case of a subdivision, combination or reclassification. 
 Such
adjustment shall be made successively whenever any event listed above shall occur. 
 4.2. Adjustment for Rights Issue.
If the Company distributes any rights, options or warrants to all holders of its Common Stock entitling them to purchase shares of Common Stock at a price per share less than the Closing Price per share on the Business Day immediately preceding the
ex-dividend date for such distribution of rights, options or warrants, the number of shares of Common Stock issuable upon exercise of each Warrant shall be adjusted in accordance with the formula: 

 

									
		 	N’ = N	 	× 	 	O + A	  	
		 		 		 	O + (A × P/M)	  	

 where: 
  

			
	N’ =	 	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant.

  

 5 

			
	N =	 	the current number of shares of Common Stock issuable upon exercise of each Warrant.
		
	O =	 	the number of shares of Common Stock outstanding on the record date for such distribution.
		
	A =	 	the number of additional shares of Common Stock issuable pursuant to such rights or warrants.
		
	P =	 	the purchase price per share of the additional shares.
		
	M =	 	the Closing Price per share of Common Stock on the record date.

The adjustment shall be made successively whenever any such rights, options or warrants are issued and shall become effective immediately
after the record date for the determination of stockholders entitled to receive the rights, options or warrants. If at the end of the period during which such rights, options or warrants are exercisable, not all rights, options or warrants shall
have been exercised, the number of shares of Common Stock issuable upon exercise of each Warrant shall be immediately readjusted to what it would have been if “N” in the above formula had been the number of shares actually issued.

 4.3. Adjustment for Other Distributions. If the Company distributes to all holders of its Common Stock any of its
assets (including cash) or debt securities or any rights, options or warrants to purchase debt securities, assets or other securities of the Company (other than Common Stock), the number of shares of Common Stock issuable upon exercise of each
Warrant shall be adjusted in accordance with the formula: 
  

									
		 	N’ = N	 	× 	 	M	  	
		 		 		 	M - F 	  	

 where: 
  

			
	N’ =	 	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant.

  

 6 

			
	N =	 	the current number of shares of Common Stock issuable upon exercise of each Warrant.
		
	M =	 	the Closing Price per share of Common Stock on the Business Day immediately preceding the ex-dividend date for such distribution.
		
	F =	 	the fair market value on the ex-dividend date for such distribution of the assets, securities, rights or warrants distributable to one share of Common Stock after taking into
account, in the case of any rights, options or warrants, the consideration required to be paid upon exercise thereof. The board of directors of the Company (the “Board of Directors”) shall reasonably determine the fair market value in good
faith.

 The adjustment shall be made successively whenever any such distribution is made and shall become
effective immediately after the record date for the determination of stockholders entitled to receive such distribution. 
 This
Section 4.3 does not apply to regular quarterly cash dividends including increases thereof or rights, options or warrants referred to in Section 4.2. If any adjustment is made pursuant to this Section 4.3 as a result of the issuance
of rights, options or warrants and at the end of the period during which any such rights, options or warrants are exercisable, not all such rights, options or warrants shall have been exercised, the Warrant shall be immediately readjusted as if
“F” in the above formula was the fair market value on the ex-dividend date for such distribution of the indebtedness or assets actually distributed upon exercise of such rights, options or warrants divided by the number of shares of Common
Stock outstanding on the ex-dividend date for such distribution. Notwithstanding anything to the contrary contained in this Section 4.3, if “M-F” in the above formula is less than $1.00, the Company may elect to, and if
“M-F” is a negative number, the Company shall, in lieu of the adjustment otherwise required by this Section 4.3, distribute to the holders of the Warrants, upon exercise thereof, the evidences of indebtedness, assets, rights, options
or warrants (or the proceeds thereof) which would have been distributed to such holders had such Warrants been exercised immediately prior to the record date for such distribution. 

4.4. Adjustment for Common Stock Issue. If the Company issues shares of Common Stock for a consideration per share less than the
Closing Price per share on the date the Company fixes the offering price of such additional shares, the number of shares of Common Stock issuable upon exercise of each Warrant shall be adjusted in accordance with the formula: 

 

									
		 	N’ = N	 	× 	 	A	  	
		 		 		 	O + P/M 	  	

 where: 
  

			
	N’ =	 	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant.

  

 7 

			
	N =	 	the current number of shares of Common Stock issuable upon exercise of each Warrant.
		
	O =	 	the number of shares outstanding immediately prior to the issuance of such additional shares.
		
	P =	 	the aggregate consideration received for the issuance of such additional shares.
		
	M =	 	the Closing Price per share on the date of issuance of such additional shares.
		
	A =	 	the number of shares outstanding immediately after the issuance of such additional shares.

The adjustment shall be made successively whenever any such issuance is made, and shall become effective immediately after such issuance.

 This Section 4.4 does not apply to: 

(1) any of the transactions described in Sections 4.2 and 4.3, 

(2) the exercise of Warrants, or the conversion or exchange of other securities convertible or exchangeable for Common Stock, or the
issuance of Common Stock upon the exercise of rights or warrants issued to the holders of Common Stock, 
 (3) Common Stock (and
options exercisable therefor) issued under bona fide employee benefit plans or stock option plans of the Company adopted by the Board of Directors and approved by the holders of Common Stock when required by law, if such Common Stock would otherwise
be covered by this Section 4.4, 
 (4) Common Stock issued in a bona fide public offering for cash, or 

(5) Common Stock issued in a bona fide private placement to non-affiliates of the Company, including without limitation the issuance of
equity as consideration or partial consideration for acquisitions from persons that are not affiliates of the Company. 
 4.5.
Adjustment for Convertible Securities Issue. If the Company issues any securities convertible into or exchangeable for Common Stock (other than securities issued in transactions described in Sections 4.2 and 4.3) for a consideration per share
of Common Stock initially deliverable upon conversion or exchange of such securities less than the Closing Price per share on the date of issuance of such securities, the number of shares of Common Stock issuable upon exercise of each Warrant shall
be adjusted in accordance with this formula: 
  

									
		 	N’ = N	 	× 	 	O + D	  	
		 		 		 	O + P/M 	  	

 where: 
  

			
	N’ =	 	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant.

  

 8 

			
	N =	 	the current number of shares of Common Stock issuable upon exercise of each Warrant.
		
	O =	 	the number of shares outstanding immediately prior to the issuance of such securities.
		
	P =	 	the aggregate consideration received for the issuance of such securities.
		
	M =	 	the Closing Price per share on the date of issuance of such securities.
		
	D =	 	the maximum number of shares deliverable upon conversion or in exchange for such securities at the initial conversion or exchange rate.

The adjustment shall be made successively whenever any such issuance is made, and shall become effective immediately after such issuance.

 If all of the Common Stock deliverable upon conversion or exchange of such securities have not been issued when such
securities are no longer outstanding, then the number of shares of Common Stock issuable upon exercise of each Warrant shall promptly be readjusted to what it would have been had the adjustment upon the issuance of such securities been made on the
basis of the actual number of shares of Common Stock issued upon conversion or exchange of such securities. 
 This
Section 4.5 does not apply to: 
 (1) convertible securities issued in a bona fide public offering for cash; or 

(2) convertible securities issued in a bona fide private placement to non-affiliates of the Company, including the issuance of
convertible securities as consideration or partial consideration for acquisitions from persons that are not affiliates of the Company. 

4.6. Adjustment for Tender or Exchange Offer. If the Company or any of its subsidiaries makes a payment in respect of a tender
offer or exchange offer for the Common Stock, and the cash and value of any other consideration included in the payment per share of the Common Stock exceeds the Closing Price of the Common Stock on the trading day next succeeding the last date on
which tenders or exchanges may be made pursuant to such tender or exchange offer, the number of shares of Common Stock issuable upon exercise of each Warrant will be increased based on the following formula: 

 

									
		 	N’ = 
No
	 	× 	 	AC + (SP’ x OS’)	  	
		 		 		 	OSo x SP’
	  	

 where, 
  

			
	N’ =	 	the adjusted number of shares of Common Stock issuable upon exercise of each Warrant;

  

 9 

			
	No =
	 	the current number of shares of Common Stock issuable upon exercise of each warrant;
		
	AC =	 	the aggregate value of all cash and any other consideration (as determined by the board of directors of the Company) paid or payable for shares purchased in such tender or
exchange offer;
		
	OSo =
	 	the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires;
		
	OS’ =	 	the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires; and
		
	SP’ =	 	the Closing Price of the Common Stock on the trading day next succeeding the date such tender or exchange offer expires.

The adjustment shall be made successively and shall become effective immediately following the date such tender or exchange offer
expires. 
 4.7. Consideration Received. For purposes of any computation respecting consideration received pursuant to
Sections 4.4, 4.5 and 4.6, the following shall apply: 
 (1) in the case of the issuance of shares of Common Stock for cash, the
consideration shall be the amount of such cash, provided that in no case shall any deduction be made for any commissions, discounts or other expenses incurred by the Company for any underwriting or other sale or disposition of the issue or otherwise
in connection therewith; 
 (2) in the case of the issuance of shares of Common Stock for a consideration in whole or in part
other than cash, the consideration other than cash shall be deemed to be the fair market value thereof as reasonably determined by the Board of Directors (irrespective of the accounting treatment thereof) and described in a board resolution which
shall be filed with the Warrant Agent; and 
 (3) in the case of the issuance of securities convertible into or exchangeable for
shares, the aggregate consideration received therefor shall be deemed to be the consideration received by the Company for the issuance of such securities plus the additional minimum consideration, if

  

 10 

 
any, to be received by the Company upon the conversion or exchange thereof for the maximum number of shares used to calculate the adjustment (the consideration in each case to be determined in
the same manner as provided in clauses (1) and (2) of this Section 4.7). 
 4.8. Defined Terms; When De
Minimis Adjustment May Be Deferred. As used in this Section 4: 
 (1) The “Closing Price” of the Common Stock
on any date of determination means: 
  

	 	(i)	the closing sale price for the regular trading session (without considering after hours or other trading outside regular trading session hours) of the Common Stock
(regular way) on the New York Stock Exchange on that date (or, if no closing price is reported, the last reported sale price during that regular trading session), 

 

	 	(ii)	if the Common Stock is not listed for trading on the New York Stock Exchange on that date, as reported in the composite transactions for the principal United States
securities exchange on which the Common Stock is so listed, 

  

	 	(iii)	if the Common Stock is not so reported, the last quoted bid price for the Common Stock in the over-the-counter market as reported by the OTC Bulletin Board, the
National Quotation Bureau or similar organization, or 

  

	 	(iv)	if the Common Stock is not so quoted, the average of the mid-point of the last bid and ask prices for the Common Stock from at least three nationally recognized
investment banking firms that the Company selects for this purpose; 

 (2) “ex-dividend date” means the
first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive the issuance or distribution in question; 

(3) “trading day” means, with respect to the Common Stock or any other security, a day during which (i) trading in the
Common Stock or such other security generally occurs, (ii) there is no market disruption event (as defined below) and (iii) a Closing Price for the Common Stock or such other security (other than a Closing Price referred to in the next to
last clause of such definition) is available for such day; provided that if the Common Stock or such other security is not admitted for trading or quotation on or by any exchange, bureau or other organization, “trading day” will
mean any Business Day; 
 (4) “market disruption event” means, with respect to the Common Stock or any other security,
the occurrence or existence of more than one-half hour period in the aggregate or any scheduled trading day for the Common Stock or such other security of any suspension or 

 

 11 

 
limitation imposed on trading (by reason of movements in price exceeding limits permitted by the stock exchange or otherwise) in the Common Stock or such other security or in any options,
contract, or future contracts relating to the Common Stock or such other security, and such suspension or limitation occurs or exists at any time before 1:00 p.m. (New York time) on such day; and 

(5) “Business Day” means, any day on which the New York Stock Exchange is open for trading and which is not a Saturday, a
Sunday or any other day on which banks in the City of New York, New York, are authorized or required by law to close. 
 No
adjustment in the number of shares of Common Stock issuable upon exercise of each Warrant need be made unless the adjustment would require an increase or decrease of at least 1% in such number. Any adjustments that are not made shall be carried
forward and taken into account in any subsequent adjustment. 
 All calculations under this Section 4 shall be made to the
nearest cent or to the nearest 1/100th of a share, as the case may be. 
 4.9. When No Adjustment Required. No adjustment
need be made for a transaction referred to in Sections 4.2, 4.3, 4.4, 4.5 or 4.6 if Warrant holders are to participate, without requiring the Warrants to be exercised, in the transaction on a basis and with notice that the Board of Directors
reasonably determines to be fair and appropriate in light of the basis and notice on which holders of Common Stock participate in the transaction. 

No adjustment need be made for a change in the par value or no par value of the Common Stock. 

To the extent the Warrants become convertible into cash, no adjustment need be made thereafter as to the amount of cash into which such
Warrants are exercisable. Interest will not accrue on the cash. 
 4.10. Notice of Adjustment. Whenever the number of
shares of Common Stock issuable upon exercise of each Warrant is adjusted, the Company shall provide the notices required by Section 4.19 hereof. 

4.11. Notice of Certain Transactions. If: 

(1) the Company takes any action that would require an adjustment in the Warrant Price pursuant to Sections 4.1, 4.2, 4.3, 4.4, 4.5 or
4.6 and if the Company does not arrange for Warrant holders to participate pursuant to Section 4.9; 
 (2) the Company
takes any action that would require a supplemental Warrant Agreement pursuant to Section 4.12; or 
 (3) there is a
liquidation or dissolution of the Company, 
  

 12 

 the Company shall mail to Warrant holders a notice stating the proposed record date for a
dividend or distribution or the proposed effective date of a subdivision, combination, reclassification, consolidation, merger, transfer, lease, liquidation or dissolution. The Company shall mail the notice at least 15 days before such date. Failure
to mail the notice or any defect in it shall not affect the validity of the transaction. 
 4.12. Reorganization of
Company. If the Company consolidates or merges with or into, or transfers or sells all or substantially all its assets to, any person, upon consummation of such transaction the Warrants shall automatically become exercisable for the kind and
amount of securities, cash or other assets which the holder of a Warrant would have owned immediately after the consolidation, merger, transfer or sale if such holder had exercised the Warrant immediately before the effective date of the
transaction; provided that (i) if the holders of Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and
amount of securities, cash or other assets for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of Common Stock in such consolidation or merger that
affirmatively make such election or (ii) if a tender or exchange offer shall have been made to and accepted by the holders of Common Stock under circumstances in which, upon completion of such tender or exchange offer, the maker thereof,
together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act)
and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the outstanding shares of Common Stock, the holder of a Warrant shall
be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or
exchange offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly
equivalent as possible to the adjustments provided for in this Section 4. Concurrently with the consummation of any such transaction, the corporation or other entity formed by or surviving any such consolidation or merger if other than the
Company, or the person to which such sale or conveyance shall have been made, shall enter into a supplemental Warrant Agreement so providing and further providing for adjustments which shall be as nearly equivalent as may be practical to the
adjustments provided for in this Section 4. The successor Company shall mail to Warrant holders a notice describing the supplemental Warrant Agreement. 

If the issuer of securities deliverable upon exercise of Warrants under the supplemental Warrant Agreement is an affiliate of the formed,
surviving, transferee or lessee corporation, that issuer shall join in the supplemental Warrant Agreement. 
 If this
Section 4.12 applies, Sections 4.1, 4.2, 4.3, 4.4, 4.5 and 4.6 do not apply. 
 4.13. Warrant Agent’s
Disclaimer. The Warrant Agent has no duty to determine when an adjustment under this Section 4 should be made, how it should be made or what it should be. The Warrant Agent has no duty to determine whether any provisions of a supplemental
Warrant Agreement under Section 4.12 are correct. The Warrant Agent makes no representation as to the validity or value of any securities or assets issued upon exercise of Warrants. The Warrant Agent shall not be responsible for the
Company’s failure to comply with this Section 4. 
  

 13 

 4.14. When Issuance or Payment May Be Deferred. In any case in which this
Section 4 shall require that an adjustment in the number of shares of Common Stock issuable upon exercise of each Warrant be made effective as of a record date for a specified event, the Company may elect to defer until the occurrence of such
event (i) issuing to the holder of any Warrant exercised after such record date the Warrant Shares and other capital stock of the Company, if any, issuable upon such exercise over and above the Warrant Shares and other capital stock of the
Company, if any, issuable upon such exercise on the basis of the number of shares of Common Stock issuable upon exercise of each Warrant and (ii) paying to such holder any amount in cash in lieu of a fractional share pursuant to
Section 4.18 hereof; provided, however, that the Company shall deliver to such holder a due bill or other appropriate instrument evidencing such holder’s right to receive such additional Warrant Shares, other capital stock
and cash upon the occurrence of the event requiring such adjustment. 
 4.15. Adjustment in Warrant Price. Upon each
event that provides for an adjustment of the number of shares of Common Stock issuable upon exercise of each Warrant pursuant to this Section 4, each Warrant outstanding prior to the making of the adjustment shall thereafter have an adjusted
Warrant Price (calculated to the nearest ten millionth) obtained from the following formula: 
  

									
		 	E’ = E	 	× 	 	N	  	
		 		 		 	N’	  	

 where: 
  

			
	E’ =	 	the adjusted Warrant Price.
		
	E =	 	the Warrant Price prior to adjustment.
		
	N’ =	 	the adjusted number of Warrant Shares issuable upon exercise of a Warrant by payment of the adjusted Warrant Price.
		
	N =	 	the number of Warrant Shares previously issuable upon exercise of a Warrant by payment of the Warrant Price prior to adjustment.

Following any adjustment to the Warrant Price pursuant to this Section 4, the amount payable, when adjusted and together with any
consideration allocated to the issuance of the Warrants, shall never be less than the par value per Warrant Share at the time of such adjustment. Such adjustment shall be made successively whenever any event listed above shall occur. 

 

 14 

 4.16. Form of Warrants. Irrespective of any adjustments in the number or kind of
shares issuable upon the exercise of the Warrants or the Warrant Price, Warrants theretofore or thereafter issued may continue to express the same number and kind of shares and Warrant Price as are stated in the Warrants initially issuable pursuant
to this Agreement. 
 4.17. Other Dilutive Events. In case any event shall occur affecting the Company, as to which the
provisions of this Section 4 are not strictly applicable, but would impact the holders of Warrants adversely as compared to holders of Common Stock, and the failure to make any adjustment would not fairly protect the purchase rights represented
by the Warrants in accordance with the essential intent and principles of this Section then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national
standing which shall give their opinion upon the adjustment, if any, on a basis consistent with the essential intent and principles established in this Section 4, necessary to preserve, without dilution, the purchase rights represented by the
Warrants. 
 4.18. Fractional Interests. The Company shall not be required to issue fractional shares of Common Stock on
the exercise of Warrants. If more than one Warrant shall be presented for exercise in full at the same time by the same holder, the number of full shares of Common Stock which shall be issuable upon the exercise thereof shall be computed on the
basis of the aggregate number of shares of Common Stock purchasable on exercise of the Warrants so presented. If any fraction of a shares of Common Stock would, except for the provisions of this Section 4.18, be issuable on the exercise of any
Warrants (or specified portion thereof), the Company shall pay an amount in cash equal to the fair market value on the day immediately preceding the date the Warrant is presented for exercise, multiplied by such fraction. 

4.19. Notices to Warrant Holders. Upon any adjustment of the Warrant Price pursuant to Section 4, the Company shall promptly
thereafter, and in any event within five days, (i) cause to be filed with the Warrant Agent a certificate executed by the Chief Financial Officer of the Company setting forth the number of shares of Common Stock issuable upon exercise of each
Warrant after such adjustment and setting forth in reasonable detail the method of calculation and the facts upon which such calculations are based, and (ii) cause to be given to each of the registered holders of the Warrant Certificates at his
address appearing on the Warrant Register written notice of such adjustments by first-class mail, postage prepaid. Where appropriate, such notice may be given in advance and included as a part of the notice required to be mailed under the other
provisions of this Section 4.19. The Warrant Agent shall be fully protected in relying on any such certificate and on any adjustment therein contained and shall not be deemed to have knowledge of such adjustment unless and until it shall have
received such certificate. 
 In case: 

(a) the Company shall authorize the issuance to all holders of shares of Common Stock of rights, options or warrants to subscribe for or
purchase shares of Common Stock or of any other subscription rights or warrants; or 
  

 15 

 (b) the Company shall authorize the distribution to all holders of shares of Common Stock of
evidences of its indebtedness or assets (other than regular cash dividends or dividends payable in shares of Common Stock or distributions referred to in Section 4.2 hereof); or 

(c) of any consolidation or merger to which the Company is a party and for which approval of any stockholders of the Company is required,
or of the conveyance or transfer of the properties and assets of the Company substantially as an entirety, or of any reclassification or change of Common Stock issuable upon exercise of the Warrants (other than a change in par value, or from par
value to no par value, or from no par value to par value, or as a result of a subdivision or combination), or a tender offer or exchange offer for shares of Common Stock; or 

(d) of the voluntary or involuntary dissolution, liquidation or winding up of the Company; or 

(e) the Company proposes to take any action not specified above which would require an adjustment of the Warrant Price pursuant to
Section 4 hereof; 
 then the Company shall cause to be filed with the Warrant Agent and shall cause to be given to each of
the registered holders of the Warrant Certificates at his address appearing on the Warrant register, at least 10 calendar days prior to the applicable record date hereinafter specified, or as promptly as practicable under the circumstances in the
case of events for which there is no record date, by first-class mail, postage prepaid, a written notice stating (i) the date as of which the holders of record of shares of Common Stock to be entitled to receive any such rights, options,
warrants or distribution are to be determined, or (ii) the initial expiration date set forth in any tender offer or exchange offer for shares of Common Stock, or (iii) the date on which any such consolidation, merger, conveyance, transfer,
dissolution, liquidation or winding up is expected to become effective or consummated, and the date as of which it is expected that holders of record of shares of Common Stock shall be entitled to exchange such shares for securities or other
property, if any, deliverable upon such reclassification, consolidation, merger, conveyance, transfer, dissolution, liquidation or winding up. The failure to give the notice required by this Section 4.19 or any defect therein shall not affect
the legality or validity of any distribution, right, option, warrant, consolidation, merger, conveyance, transfer, dissolution, liquidation or winding up, or the vote upon any action. 

Nothing contained in this Agreement or in any of the Warrant Certificates shall be construed as conferring upon the holders thereof the
right to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter, or any rights whatsoever as stockholders of the Company. 

5. Transfer and Exchange of Warrants. 

5.1. Restriction on Transfer and Ownership of Warrants. Notwithstanding anything to the contrary contained herein, no Person may
Beneficially Own or Constructively Own more than 9.8% of the outstanding Warrants, or such other percentage as determined by the Board of Directors in its sole and absolute discretion. Any Transfer of Warrants in violation of the foregoing
restriction will be subject to the provisions in Section 7.2.1(b) of the Company’s charter as though such Transfer of Warrants were a Transfer of shares of Capital Stock that 

 

 16 

 
violated the Stock Ownership Limit. For purposes of the foregoing restriction, Warrants will be treated as though they are shares of Capital Stock for purposes of the definitions and other
provisions in Article VII of the Company’s charter, including for purposes of the definitions of Beneficial Ownership and Constructive Ownership therein. Defined terms used in this Section 5.1 that are not otherwise defined in this
Agreement shall have the meaning provided for in the Company’s charter. 
 5.2. Registration of Transfer. The
Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate
instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the
Warrant Agent to the Company from time to time upon request. 
 5.3. Procedure for Surrender of Warrants. Warrants may be
surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the registered holder of the Warrants so
surrendered, representing an equal aggregate number of Warrants; provided, however, that in the event that a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in
exchange therefor until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend. 

5.4. Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will
result in the issuance of a warrant certificate for a fraction of a warrant. 
 5.5. Service Charges. No service charge
shall be made for any exchange or registration of transfer of Warrants. 
 5.6. Warrant Execution and Countersignature.
The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the
Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose. 
 6. Redemption.

 6.1. Redemption. Not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any
time while they are exercisable and so long as an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants is current and a prospectus relating to the shares of Common Stock is available throughout
the “30-day redemption period” (defined below) and prior to their expiration, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant (“Redemption Price”), provided
that the reported last sales price of the Common Stock 
  

 17 

 
equals or exceeds $         per share (subject to adjustment in accordance with Section 4 hereof), for any twenty (20) trading days within any
thirty (30) trading day period ending on the third business day prior to the date on which notice of redemption is given. 

6.2. Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants, the Company
shall fix a date for the redemption. Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than 30 days prior to the date fixed for redemption (the “30-day redemption period”) to the registered
holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the registered
holder received such notice. 
 6.3. Exercise After Notice of Redemption. The Company may, in its sole discretion,
require all record holders of Warrants that wish to exercise such Warrants to exercise such Warrants for cash (or on a “cashless basis” in accordance with Section 3.3.1 of this Agreement) at any time after notice of redemption shall
have been given by the Company pursuant to Section 6.2 hereof and prior to the time and date fixed for redemption. On and after the redemption date, the record holder of the Warrants shall have no further rights except to receive, upon
surrender of the Warrants, the Redemption Price. 
 7. Other Provisions Relating to Rights of Holders of Warrants. 

7.1. No Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a stockholder of
the Company, including, without limitation, the right to receive dividends, or other distributions, including the right to participate in any liquidation of the Company (as described in the Registration Statement), exercise any preemptive rights, to
vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter. 

7.2. Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the
Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the
Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable
by anyone. 
 7.3. Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its
authorized but unissued shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement. 

7.4. Registration of Common Stock. The Company agrees that prior to the commencement of the Exercise Period, it shall use its best
efforts to file with the Securities and Exchange Commission a post-effective amendment to the Registration Statement, or a new registration statement, for the registration, under the Act, of, and it shall use its best efforts to take such action as
is necessary to qualify for sale, in those states in which the Warrants were initially offered by the Company and are not otherwise exempt from qualification under state 

 

 18 

 
securities laws, the Common Stock issuable upon exercise of the Warrants. The Company will use its best efforts to cause the same to become effective prior to commencement of the Exercise Period
and to maintain the effectiveness of such registration statement and a current prospectus related thereto until the expiration of the Warrants in accordance with the provisions of this Agreement. The provisions of this Section 7.4 may not be
modified, amended or deleted without the prior written consent of Lazard and Stifel. 
 8. Concerning the Warrant Agent and Other
Matters. 
 8.1. Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be
imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 8.2. Resignation, Consolidation, or Merger of Warrant Agent. 

8.2.1. Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties
and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the
Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of 30 days after it has been notified in writing of such resignation or incapacity by the
Warrant Agent or by the holder of the Warrant (who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the
appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation duly incorporated, validly existing and in good standing under the laws of
its jurisdiction of incorporation and authorized under such laws to exercise the powers of a warrant agent and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with
all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary
or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and
upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority,
powers, rights, immunities, duties, and obligations. 
 8.2.2. Notice of Successor Warrant Agent. In the event a
successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the transfer agent for the Common Stock not later than the effective date of any such appointment. 

 

 19 

 8.2.3. Merger or Consolidation of Warrant Agent. Any corporation into which the
Warrant Agent may be merged or with which it may be consolidated or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further
act. 
 8.3. Fees and Expenses of Warrant Agent. 

8.3.1. Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent
hereunder and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder. 

8.3.2. Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed,
acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement. 

8.4. Liability of Warrant Agent. 

8.4.1. Reliance on Company Statement. Whenever in the performance of its duties under this Warrant Agreement, the Warrant Agent
shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed)
may be deemed to be conclusively proved and established by a statement signed by the President or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or
suffered in good faith by it pursuant to the provisions of this Agreement. 
 8.4.2. Indemnity. The Warrant Agent shall
be liable hereunder only for its own negligence, willful misconduct or bad faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for
anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result of the Warrant Agent’s negligence, willful misconduct, or bad faith. 

8.4.3. Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect
to the validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant; nor shall it be responsible to
make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by
any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock will when
issued be valid and fully paid and nonassessable. 
  

 20 

 8.5. Acceptance of Agency. The Warrant Agent hereby accepts the agency established by
this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all
moneys received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of Warrants. 
 9. Miscellaneous
Provisions. 
 9.1. Successors. All the covenants and provisions of this Agreement by or for the benefit of the
Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns. 
 9.2.
Notices. Any notice, statement or demand authorized by this Warrant Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight
delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows: 

Madison Square Capital, Inc. 

331 West
57th Street, #363 

New York, New York 10019 

Attn: Paul A. Ullman, Chief Executive Officer 

Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on
the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address
is filed in writing by the Warrant Agent with the Company), as follows: 
 Registrar and Transfer Company

 10 Commerce Drive 

Cranford, New Jersey 07016 

Attn: 

with a copy in each case to: 

Hunton & Williams LLP 

Bank of America Plaza, Suite 4100 

600 Peachtree Street, N.E. 

Atlanta, Georgia 30308 

Attn: Ronald J. Lieberman, Esq. 

Facsimile: (404) 888-4190 

and 

Gibson, Dunn & Crutcher LLP 

1050 Connecticut Avenue, N.W. 

Washington, D.C. 

Attn: Howard B. Adler, Esq. 

Facsimile: (202) 955-0539 
  

 21 

 and 

Lazard Capital Markets LLC 

30 Rockefeller Plaza,
60th Floor 

New York, NY 10020 

Attn: David McMillan 

Facsimile: (212) 632-6984 

and 

Stifel, Nicolaus & Company, Incorporated 

501 North Broadway 

St. Louis, MO 63102 

Attn: 

Facsimile: 

9.3. Applicable law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all
respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim
against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such
jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenience forum. Any such process or summons to be served upon the Company may be
served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2 hereof. Such mailing shall be deemed personal service and shall be legal
and binding upon the Company in any action, proceeding or claim. 
 9.4. Persons Having Rights under this Agreement.
Nothing in this Agreement expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the registered holders
of the Warrants and, for the purposes of Sections 2.5, 6.1, 7.4, 9.2 and 9.8 hereof, the Underwriters, any right, remedy, or claim under or by reason of this Warrant Agreement or of any covenant, condition, stipulation, promise, or agreement
hereof. The Underwriters shall be deemed to be a third-party beneficiary of this Agreement with respect to Sections 2.5, 6.1, 7.4, 9.2 and 9.8 hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Warrant
Agreement shall be for the sole and exclusive benefit of the parties hereto (and the Underwriters with respect to the Sections 2.5, 6.1, 7.4, 9.2 and 9.8 hereof) and their successors and assigns and of the registered holders of the Warrants.

 9.5. Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the
office of the Warrant Agent in the township of Cranford, county of Union, State of New Jersey, for inspection by the registered holder of any Warrant. The Warrant Agent may require any such holder to submit his Warrant for inspection by it.

  

 22 

 9.6. Counterparts. This Agreement may be executed in any number of original or
facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 

9.7. Effect of Headings. The Section headings herein are for convenience only and are not part of this Warrant Agreement and shall
not affect the interpretation thereof. 
 9.8. Amendments. This Agreement may be amended by the parties hereto without
the consent of any registered holder for the purpose of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with respect to matters or questions arising
under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the registered holders. All other modifications or amendments, including any amendment to increase the Warrant
Price or shorten the Exercise Period, shall require the written consent of the registered holders of a majority of the then outstanding Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the
Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the registered holders. 
 9.9.
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof.
Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be
possible and be valid and enforceable. 
  

 23 

 IN WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the
day and year first above written. 
  

			
	MADISON SQUARE CAPITAL, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	REGISTRAR AND TRANSFER COMPANY
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

 24 

 EXHIBIT A 

(See Exhibit 4.3 to Amendment No. 11 to Form S-11/A) 

 

 25Fifth Supplemental Indenture

 Exhibit 4.1 

SUPPLEMENTAL INDENTURE 

TO THE INDENTURE 

RBS GLOBAL, INC., 

REXNORD LLC, 

THE GUARANTORS SIGNATORY HERETO 

AND 
 WELLS
FARGO BANK, NATIONAL ASSOCIATION 
 as Trustee 

 
  

FIFTH SUPPLEMENTAL INDENTURE 

Dated as of April 20, 2010 

to 
 Indenture

 Dated as of July 21, 2006 

9.50% Senior Unsecured Notes due 2014 
  

 1 

 THIS FIFTH SUPPLEMENTAL INDENTURE, dated as of April 20, 2010 (this
“Fifth Supplemental Indenture”), is by and among RBS Global, Inc., a Delaware corporation (the “Company”), Rexnord LLC, a Delaware limited liability company (“Rexnord” and, together with RBS
Global, the “Issuers”), the Guarantors and Wells Fargo Bank, National Association, as trustee (the “Trustee”). 

WHEREAS, the Issuers, the Guarantors and the Trustee are party to that certain Indenture, dated as of July 21, 2006,
providing for the issuance of 9.50% Senior Notes due 2014 (the “Notes”), as supplemented by that first supplemental indenture, dated as of July 21, 2006, that second supplemental indenture, dated as of February 7, 2007,
that third supplemental indenture dated as of April 1, 2007 and that fourth supplemental indenture dated as of February 1, 2008 (the “Indenture”); 

WHEREAS, the Issuers originally issued $485 million aggregate principal amount of the Notes and, pursuant to the second
supplemental indenture, issued $310 million aggregate principal amount of Additional Securities (as defined in the Indenture); 

WHEREAS, Section 9.02 of the Indenture provides that the Indenture may be amended with the consent of the Holders of at least
a majority in principal amount of the Notes then outstanding (including without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, Notes) (subject to certain exceptions); 

WHEREAS, the Issuers desire and have requested the Trustee to join with them in entering into this Fifth Supplemental Indenture
for the purpose of amending the Indenture in certain respects as permitted by Section 9.02 of the Indenture; 

WHEREAS, the execution and delivery of this Fifth Supplemental Indenture has been authorized by the Board of Directors of each
Issuer and of each Guarantor; 
 WHEREAS, (1) the Issuers have received the consent of the Holders of at least a
majority in principal amount of the outstanding Notes and have satisfied all other conditions precedent, if any, provided under the Indenture to enable the Issuers, the Guarantors and the Trustee to enter into this Fifth Supplemental Indenture, all
as certified by an Officers’ Certificate, delivered to the Trustee simultaneously with the execution and delivery of this Fifth Supplemental Indenture as contemplated by Section 9.02 of the Indenture, and (2) the Issuers have
delivered to the Trustee simultaneously with the execution and delivery of this Fifth Supplemental Indenture an Officer’s Certificate and Opinion of Counsel relating to this Fifth Supplemental Indenture as contemplated by Section 9.06 of
the Indenture; and 
 NOW, THEREFORE, in consideration of the above premises, each party hereby agrees, for the benefit
of the others and for the equal and ratable benefit of the Holders of the Notes, as follows: 
 SECTION 1. Capitalized Terms.
Capitalized terms used herein but not defined shall have the meanings assigned to them in the Indenture. 
 SECTION 2. Deletion of
Definitions and Related References. Section 1.01 of the Indenture is hereby amended to delete in their entirety all terms and their respective definitions for which all references are eliminated in the Indenture as a result of the
amendments set forth in Section 3 of this Fifth Supplemental Indenture. 
 SECTION 3. Amendments to the Indenture. The
Indenture is hereby amended by deleting the following sections of the Indenture and all references thereto in the Indenture in their entirety: 
  

			
	Section 4.02	  	(Reports and Other Information)
		
	Section 4.03	  	(Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock)

 

 2 

			
	Section 4.04	  	(Limitation on Restricted Payments)
		
	Section 4.05	  	(Dividend and Other Payment Restrictions Affecting Subsidiaries)
		
	Section 4.06	  	(Asset Sales)
		
	Section 4.07	  	(Transactions with Affiliates)
		
	Section 4.08	  	(Change of Control)
		
	Section 4.09	  	(Compliance Certificate)
		
	Section 4.10	  	(Further Instruments and Acts)
		
	Section 4.11	  	(Future Guarantors)
		
	Section 4.12	  	(Liens)
		
	Section 4.14	  	(Maintenance of Office or Agency)
		
	Section 5.01	  	(When Company May Merge or Transfer Assets - deleting clauses (a)(iii), (a)(iv), (a)(vii), and (b)(iii))
		
	Section 6.01	  	(Events of Default - deleting clauses (c), (d), (e), (f), (g), (h) and (i))
		
	Section 6.12	  	(Waiver of Stay or Extension Laws)
		
	Section 8.02	  	(Conditions to Defeasance - deleting clauses (ii), (iii), (iv), (v), (vii) and (viii))

SECTION 4. Severability. In case any provision in this Fifth Supplemental Indenture shall be invalid, illegal or unenforceable, the
validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 SECTION 5.
Successors. All agreements of the Issuers, the Guarantors and the Trustee in this Fifth Supplemental Indenture and the Notes shall bind their respective successors. 

SECTION 6. Effectiveness. The provisions of Sections 2 and 3 of this Fifth Supplemental Indenture shall be effective at the time the
Issuers accepts for purchase a majority in principal amount of the outstanding Notes issued under the Indenture. 
 SECTION 7. Endorsement
and Change of Form of Notes. Any Notes authenticated and delivered after the close of business on the date that this Fifth Supplemental Indenture becomes effective may be affixed to, stamped, imprinted or otherwise legended by the Trustee,
with a notation as follows: 
 “Effective as of [            ], 2010, the
restrictive covenants of the Issuers and certain of the Events of Default and other provisions have been eliminated, as provided in the Fifth Supplemental Indenture, dated as of April 20, 2010. Reference is hereby made to said Fifth
Supplemental Indenture, copies of which are on file with the Trustee, for a description of the amendments made therein.” 
 SECTION 8.
Ratification of Indenture; Fifth Supplemental Indenture Part of Indenture. Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in
full force and effect. This Fifth Supplemental Indenture shall form a part of the Indenture for all purposes, and every holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby. Except as amended hereby, the
Indenture, the Notes and the Guarantees are in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. Subject to Section 13.01 of the Indenture, in the case of conflict
between the Indenture and this Fifth Supplemental Indenture, the provisions of this Fifth Supplemental Indenture shall control. 
 SECTION 9.
Governing Law. THIS FIFTH SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.  
  

 3 

 SECTION 10. The Trustee. The Trustee shall not be responsible in any manner whatsoever for or
in respect of the validity or sufficiency of this Fifth Supplemental Indenture or for or in respect of the recitals contained herein, all of which are made solely by the Issuers and the Guarantors. Except as otherwise expressly provided herein, no
duties, responsibilities or liabilities are assumed, or shall be construed to be assumed by the Trustee by reason of this Fifth Supplemental Indenture. This Supplemental Indenture is executed and accepted by the Trustee subject to all the terms and
conditions set forth in the Indenture with the same force and effect as if those terms and conditions were repeated at length herein and made applicable to the Trustee with respect hereto. In entering into this Fifth Supplemental Indenture, the
Trustee shall be entitled to the benefit of every provision of the Indenture relating to the conduct or affecting the liability or affording protection to the Trustee, whether or not elsewhere herein so provided. 

SECTION 11. Counterparts. The parties may sign any number of copies of this Fifth Supplemental Indenture. Each signed copy shall be an
original, but all of them together represent the same agreement. 
 SECTION 12. Effect of Headings. The Section headings herein
are for convenience only and shall not effect the construction of this Fifth Supplemental Indenture. 
 [The rest of this page
has been intentionally left blank] 
  

 4 

 IN WITNESS WHEREOF, the parties hereto have caused this Fifth Supplemental Indenture
to be duly executed as of the day and year written above. 
  

			
	RBS GLOBAL, INC.
		
	By:	 	 /s/ Patricia M. Whaley

	Name:	 	Patricia M. Whaley
	Title:	 	Vice President, General Counsel and Secretary
	
	REXNORD LLC
		
	By:	 	 /s/ Patricia M. Whaley

	Name:	 	Patricia M. Whaley
	Title:	 	Vice President, General Counsel and Secretary
	
	 WELLS FARGO BANK, NATIONAL ASSOCIATION,

as Trustee

		
	By:	 	 /s/ Jayne Sillman

	Name:	 	Jayne Sillman
	Title:	 	Vice President

			
	THE FALK SERVICE CORPORATION
	PRAGER INCORPORATED
	PT COMPONENTS, INC.
	RBS ACQUISITION CORPORATION
	RBS CHINA HOLDINGS, L.L.C.
	REXNORD INDUSTRIES, LLC
	REXNORD INTERNATIONAL INC.
	W.M. BERG INC.
	REXNORD-ZURN HOLDINGS, INC.
	OEI, INC.
	OEP, INC.
	KRINKLES, INC.
	KRINKLES EUROPE U.S.A., INC.
	KRINKLES CANADA U.S.A., INC.
	ZURCO, INC.
	ZURN INTERNATIONAL, INC.
	ZURN PEX, INC.
	ENVIRONMENTAL ENERGY COMPANY
	HL CAPITAL CORP.
	ZURNACQ OF CALIFORNIA, INC.
	ZURN CONSTRUCTORS, INC.
	GARY CONCRETE PRODUCTS, INC.
	SANITARY-DASH MANUFACTURING CO., INC.
	ZURN EPC SERVICES, INC.
	USI ATLANTIC CORP.
	ZURN INDUSTRIES, LLC
	GA INDUSTRIES HOLDINGS, LLC
	GA INDUSTRIES, LLC
	RODNEY HUNT COMPANY, INC.
		
	By:	 	 /s/ Patricia M. Whaley

	Name:	 	Patricia M. Whaley
	Title:	 	Vice President, General Counsel and Secretary

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]